Literature DB >> 8648662

Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa.

F E McCutchan1, A W Artenstein, E Sanders-Buell, M O Salminen, J K Carr, J R Mascola, X F Yu, K E Nelson, C Khamboonruang, D Schmitt, M P Kieny, J G McNeil, D S Burke.   

Abstract

Human immunodeficiency virus type 1 isolates of clade E, known to be largely responsible for the fulminating epidemic in Southeast Asia, have been derived exclusively from Asia and Africa. Here we provide full or partial sequences of the envelope glycoprotein gene from 13 additional clade E isolates from Asia representing patients in both early and late stages of disease. More extensive comparison of isolates within clade E by geographic locale, stage of disease, and year of isolation is now possible. The genetic diversity of clade E isolates from Asia, particularly among those derived from early-stage patients, is restricted compared with African isolates (mean interisolate distances in gp120, 5.4 and 20.2%, respectively). However, patients hospitalized with AIDS-related illnesses in Thailand harbored clade E isolates exhibiting broader interisolate diversity and with highly heterogeneous third hypervariable loop sequences. An additional pair of cysteine residues, predicting a novel disulfide bridge and present in 80% of clade E isolates from Asia, was uniformly absent from six African isolates. Clade E isolates in Thailand from early-stage subjects continue to be genetically similar to potential vaccine prototype strains, providing a favorable environment for the evaluation of genotype E candidate vaccines. However, evidence of increasing interisolate diversity is appearing among late-stage patients in Asia. This diversification of the clade E virus, if sustained, may impact preventive vaccine development strategies.

Entities:  

Keywords:  Africa; Asia; Biology; Comparative Studies; Developing Countries; Diseases; Examinations And Diagnoses; Genetics; Hiv Infections; Laboratory Examinations And Diagnoses; Laboratory Procedures; Physiology; Proteins; Research Methodology; Research Report; Studies; Vaccines; Viral Diseases

Mesh:

Substances:

Year:  1996        PMID: 8648662      PMCID: PMC190203     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

Authors:  B R Starcich; B H Hahn; G M Shaw; P D McNeely; S Modrow; H Wolf; E S Parks; W P Parks; S F Josephs; R C Gallo
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

2.  Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1.

Authors:  M Kowalski; J Potz; L Basiripour; T Dorfman; W C Goh; E Terwilliger; A Dayton; C Rosen; W Haseltine; J Sodroski
Journal:  Science       Date:  1987-09-11       Impact factor: 47.728

3.  The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials.

Authors:  M L Kalish; A Baldwin; S Raktham; C Wasi; C C Luo; G Schochetman; T D Mastro; N Young; S Vanichseni; H Rübsamen-Waigmann
Journal:  AIDS       Date:  1995-08       Impact factor: 4.177

4.  Detection of diverse HIV-1 genetic subtypes in the USA.

Authors:  S K Brodine; J R Mascola; P J Weiss; S I Ito; K R Porter; A W Artenstein; F C Garland; F E McCutchan; D S Burke
Journal:  Lancet       Date:  1995-11-04       Impact factor: 79.321

5.  Evolutionary trees from DNA sequences: a maximum likelihood approach.

Authors:  J Felsenstein
Journal:  J Mol Evol       Date:  1981       Impact factor: 2.395

6.  Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.

Authors:  K Javaherian; A J Langlois; C McDanal; K L Ross; L I Eckler; C L Jellis; A T Profy; J R Rusche; D P Bolognesi; S D Putney
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

8.  Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand.

Authors:  X F Yu; Z Wang; C Beyrer; D D Celentano; C Khamboonruang; E Allen; K Nelson
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Effects on CD4 binding of anti-peptide sera to the fourth and fifth conserved domains of HIV-1 gp120.

Authors:  B Ardman; M Kowalski; J Bristol; W Haseltine; J Sodroski
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

10.  Neutralizing monoclonal antibodies to the AIDS virus.

Authors:  E K Thomas; J N Weber; J McClure; P R Clapham; M C Singhal; M K Shriver; R A Weiss
Journal:  AIDS       Date:  1988-02       Impact factor: 4.177

View more
  18 in total

1.  High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations.

Authors:  J C Zong; D M Ciufo; D J Alcendor; X Wan; J Nicholas; P J Browning; P L Rady; S K Tyring; J M Orenstein; C S Rabkin; I J Su; K F Powell; M Croxson; K E Foreman; B J Nickoloff; S Alkan; G S Hayward
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques.

Authors:  S Himathongkham; N S Halpin; J Li; M W Stout; C J Miller; P A Luciw
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians.

Authors:  M R Betts; J Krowka; C Santamaria; K Balsamo; F Gao; G Mulundu; C Luo; N N'Gandu; H Sheppard; B H Hahn; S Allen; J A Frelinger
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Genetic variation in a human immunodeficiency virus type 2 live-virus Macaca nemestrina vaccine model.

Authors:  A Radaelli; G Kraus; A Schmidt; P Badel; J McClure; S L Hu; W Morton; C De Giuli Morghen; F Wong-Staal; D Looney
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes.

Authors:  N L Michael; S A Herman; S Kwok; K Dreyer; J Wang; C Christopherson; J P Spadoro; K K Young; V Polonis; F E McCutchan; J Carr; J R Mascola; L L Jagodzinski; M L Robb
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

6.  Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E.

Authors:  J P Anderson; A G Rodrigo; G H Learn; A Madan; C Delahunty; M Coon; M Girard; S Osmanov; L Hood; J I Mullins
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

7.  Search for the mechanism of genetic variation in the pro gene of human immunodeficiency virus.

Authors:  I M Rouzine; J M Coffin
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

8.  Murine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins.

Authors:  Robert E Sealy; Bart G Jones; Sherri L Surman; Kristen Branum; Nanna M Howlett; Patricia M Flynn; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2015-11-06       Impact factor: 2.257

9.  Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies.

Authors:  James M Binley; Terri Wrin; Bette Korber; Michael B Zwick; Meng Wang; Colombe Chappey; Gabriela Stiegler; Renate Kunert; Susan Zolla-Pazner; Hermann Katinger; Christos J Petropoulos; Dennis R Burton
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 10.  Recombination in HIV: an important viral evolutionary strategy.

Authors:  D S Burke
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.